A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

NCT01597648 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus I

Interventions

DRUG: Maraviroc
DRUG: Combivir
DRUG: GSK2838510

Sponsor

GlaxoSmithKline